Professor Bonnie Mallard PhD
Professor of Immunology and Immunogenetics in the Department of Pathobiology, University of Guelph. Dr. Mallard’s research program focusses on genetic regulation of the immune system in mammals and its impact on disease resistance. She is also interested in the impact of immunoceuticals on the immune system, including the role of Vitamin D. She is winner of numerous awards, including the prestigious Governor General’s Award for Innovation and the NSERC Synergy Prize for her work in immunogenetics.
Dr Wendi Roscoe PhD
PhD in Human Physiology, Honours Degree in Genetics, Certified Holistic Nutritionist. Dr Roscoe is passionate about feeling great — both mentally and physically — and understanding how the brain and body work together at their best. She has spent her life studying what fuels energy, focus, vitality, and long-term health, and she loves helping others achieve that same sense of well-being.
Professor Niel Karrow PhD
Professor of Immunology and Immunotoxicology, Department of Animal BioScience, University of Guelph. Dr. Karrow’s research interests focus on innate immunoregulation, immunotoxicology and immunogenetics. This includes identifying genetic markers associated with inflammatory diseases, assessing the effects of maternal inflammatory stress on the developing fetal neuroendocrine-immune system, assessing efficacy of immunoceuticals, and characterizing the immunotoxicity of microbial toxins.
Dr Thomas Ichim PhD
With an impressive portfolio of scientific accomplishments, Dr. Ichim has made a name for himself as a successful biotechnology entrepreneur who founded/co-founded numerous companies throughout his career, such as Batu Biologics, Inc., Medvax Pharma Corp., ToleroTech Inc., bioRASI, and OncoMune LLC. With 50-plus patents and patent applications to his name, Dr. Ichim is a pioneer in the field of stem cell therapy and cellular product development with extensive experience navigating FDA regulatory pathways. Dr. Ichim obtained his BSc in Biology from the University of Waterloo (Ontario, Canada), his MSc in Microbiology and Immunology from the University of Western Ontario (London, Ontario) and, finally a Ph.D. in Immunology at the University of Sciences Arts & Technology based out of Olveston Monserrat.
Professor Byram Bridle PhD
Associate Professor of Viral Immunology and Cancer Biology, Department of Pathobiology, University of Guelph. Dr. Bridle’s lab develops novel, highly targeted biotherapies for the treatment of cancers. Two approaches are combined in his research program: (1) cancer immunotherapy that directs the power of a patient’s immune system against their own tumour(s) and, (2) oncolytic virotherapy, which utilizes viruses that replicate in and kill only cancerous cells. An area of focus is developing a better understanding of the mechanisms underlying virus-induced cytokine storms. He is interested in how immunoceuticals, such as Vitamin D, influence the immune system and how they might be used to improve cancer outcomes.
Course Highlights
Back by popular demand, we'll host one live question and answer session each week with the lecturer for that week. The tenth week has a ”wrap up" session with at least three of the lecturers attending.
Course Curriculum
Lectures are released each Friday from January 9, 2026 Lectures Titles and Presenters: Professor Mallard Lecture 1 - An Overview of the Immune System Lecture 2 - Immunoceuticals: Vitamin D Lecture 3 - Low-Level Light Therapy Dr Roscoe Lecture 4 - Live Blood Analysis and Electromagnetic Fields Professor Karrow Lecture 5 - Immunoceuticals: K2 Lecture 6 - Immunoceuticals: Selenium Dr Ichim Lecture 7 - Immunoceuticals: Vitamin C Professor Bridle Lecture 8 - Immunoceuticals: Vitamin A Lecture 9 - Immunoceuticals & Cancers
Ready to Transform Your Health?
Take the first step towards a healthier and more vibrant lifestyle today. Join our course to unlock the secrets of nutraceuticals and alternative therapies.
$499.00